×
ADVERTISEMENT

Mohamad E. Allaf, MD

Consider Neoadjuvant, Adjuvant Targeted Therapy for RCC

Neoadjuvant targeted therapy for renal cell carcinoma is less toxic than adjuvant targeted therapy, but both should ...

AUGUST 9, 2017

Load more